<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Ph on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/ph/</link>
    <description>Recent content in Ph on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 07:59:05 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/ph/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Author Correction: &lt;i&gt;BCL6&lt;/i&gt; enables Ph&lt;sup&gt;&#43;&lt;/sup&gt; acute lymphoblastic leukaemia cells to survive &lt;i&gt;BCR-ABL1&lt;/i&gt; kinase inhibition</title>
      <link>https://cluster-site.onrender.com/posts/author-correction-ibcl6/i-enables-phsup-/sup-acute-lymphoblastic-leukaemia-cells-to-survive-ibcr-abl1/i-kinase-inhibition/</link>
      <pubDate>Mon, 23 Feb 2026 00:39:59 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/author-correction-ibcl6/i-enables-phsup-/sup-acute-lymphoblastic-leukaemia-cells-to-survive-ibcr-abl1/i-kinase-inhibition/</guid>
      <description>• Subjects Acute lymphocytic leukaemia Cancer therapeutic resistance Drug therapy TheOriginal Articlewas published on 18 May 2011 Correction to:Naturehttps://doi.org/10.1038/nature</description>
    </item>
    <item>
      <title>Author Correction: &lt;i&gt;BCL6&lt;/i&gt; enables Ph&lt;sup&gt;&#43;&lt;/sup&gt; acute lymphoblastic leukaemia cells to survive &lt;i&gt;BCR-ABL1&lt;/i&gt; kinase inhibition</title>
      <link>https://cluster-site.onrender.com/posts/author-correction-ibcl6/i-enables-phsup-/sup-acute-lymphoblastic-leukaemia-cells-to-survive-ibcr-abl1/i-kinase-inhibition/</link>
      <pubDate>Sun, 22 Feb 2026 00:40:18 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/author-correction-ibcl6/i-enables-phsup-/sup-acute-lymphoblastic-leukaemia-cells-to-survive-ibcr-abl1/i-kinase-inhibition/</guid>
      <description>• Subjects Acute lymphocytic leukaemia Cancer therapeutic resistance Drug therapy TheOriginal Articlewas published on 18 May 2011 Correction to:Naturehttps://doi.org/10.1038/nature</description>
    </item>
    <item>
      <title>HCII Ph.D. Candidate Weaves Sociotechnical Resistance at The Frame Gallery</title>
      <link>https://cluster-site.onrender.com/posts/hcii-ph.d.-candidate-weaves-sociotechnical-resistance-at-the-frame-gallery/</link>
      <pubDate>Mon, 16 Feb 2026 06:00:00 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/hcii-ph.d.-candidate-weaves-sociotechnical-resistance-at-the-frame-gallery/</guid>
      <description>• Read how PhD candidate Alicia DeVrio explores the tension between stability and collapse through woven forms. • By Amelia De Leon For Alicia DeVrio, a PhD candidate at Carnegie M</description>
    </item>
  </channel>
</rss>
